SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

PRNewsFoto/IBM

5

McKesson

MCK

McKesson, the largest U.S. pharmaceutical distributor, continues to face obstacles as the tailwind from branded drug price inflation subsides and customers look elsewhere. But its management isn’t taking the news lying down. A series of acquisitions, ongoing restructuring, and a rash of new deals are helping lessen the blow, setting in motion a roller-coaster ride of a year. McKesson was founded in 1833 and is headquartered in San Francisco.

Looking for leads, investment insights, or competitive intelligence?

CEO

John H. Hammergren

CEO Title

Chairman, President & Chief Executive Officer

Sector

Wholesalers

Industry

Wholesalers: Health Care

HQ Location

San Francisco, CA

Years on Fortune 500 List

23

Employees

68,000

Figures are for fiscal year ended March 31, 2016.Includes revenues from discontinued operations. Profile provided by S&P Global.
McKesson is also featured in these fortune lists
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$192,4876.2%
Profits ($M)$2,258.053.0%
Assets ($M)$56,563
Total Stockholder Equity ($M)$8,924
Market Value — as of March 31, 2017 ($M)$31,439
Profit Ratios
Profit as % of Revenues1.2%
Profits as % of Assets4.0%
Profits as % of Stockholder Equity25.3%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)9.70
EPS % Change (from 2015)54.7%
EPS % Change (5 year annual rate)16.2%
EPS % Change (10 year annual rate)15.1%
Total Return
Total Return to Investors (2016)-28.3%
Total Return to Investors (5 year, annualized)13.3%
Total Return to Investors (10 year, annualized)11.6%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about McKesson

DEA Whistleblower Blasts Drug Distributors, Congress Over Opioid 'Collusion'

New report highlights revolving door between DEA and industry.

Read More →
As Drug Overdoses Hit Record High, Trump Offers Little on Opioid Policy

More than 60% of overdose deaths in 2015 were related to opioid drugs.

Read More →
Supreme Court Ruling Could Save J&J Millions in Talc Cancer Lawsuits

The ruling led a St. Louis judge at J&J's urging to declare a mistrial in the latest talc case.

Read More →